background: Ticagrelor reversibly binds with the P2Y12 receptor and has a half-life of ~12 hours, therefore requiring a twice-daily maintenance dose (MD) to maintain steady-state pharmacodynamic (PD) effects. However, in clinical practice the MD is often initiated only the day after the loading dose (LD). The PD impact of skipping the evening ticagrelor MD after a LD is unknown. methods: Patients (n=27) on maintenance aspirin (81 mg/qd) and clopidogrel (75 mg/qd) were prospectively enrolled in a two phase study. In phase 1, patients received a morning 180 mg ticagrelor LD, but not the evening 90 mg MD. After a 15-day wash-out period (patients resumed clopidogrel), phase 2 was performed in which the morning 180 mg ticagrelor LD was followed by the evening 90 mg MD. PD assessments (VerifyNow, LTA and VASP) were performed at baseline, and 2 and 24 hrs after LD.
